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Apart from teratogenic and pathological effects of zinc deficiency such as the occurrence
of skin lesions, anorexia, growth retardation, depressed wound healing, altered immune
function, impaired night vision, and alterations in taste and smell acuity, characteristic
behavioral changes in animal models and human patients suffering from zinc deficiency
have been observed. Given that it is estimated that about 17% of the worldwide population
are at risk for zinc deficiency and that zinc deficiency is associated with a variety of brain
disorders and disease states in humans, it is of major interest to investigate, how these
behavioral changes will affect the individual and a putative course of a disease. Thus, here,
we provide a state of the art overview about the behavioral phenotypes observed in various
models of zinc deficiency, among them environmentally produced zinc deficient animals
as well as animal models based on a genetic alteration of a particular zinc homeostasis
gene. Finally, we compare the behavioral phenotypes to the human condition of mild
to severe zinc deficiency and provide a model, how zinc deficiency that is associated
with many neurodegenerative and neuropsychological disorders might modify the disease
pathologies.
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INTRODUCTION
Currently, an estimated 17.3% of the global population is at
risk of developing zinc deficiency (Wessells and Brown, 2012)
and a prevalence of inadequate zinc intake was estimated with
a range from 7.5% in high-income regions to 30% in South
Asia (Wessells and Brown, 2012). Zinc is an essential trace
metal in the human body that contains about 2 g zinc stored
mostly in muscle and bone tissue. However, the zinc con-
tent in the brain is surprisingly high. There, zinc is one of
the most abundant trace metals and is enriched at the pre-
synaptic compartment of nerve cells stored in specific vesicles
together with the neurotransmitter glutamate, but also acts at
the post-synapse (Bitanihirwe and Cunningham, 2009). Zinc is
able to influence synaptic plasticity (Xie and Smart, 1994; Lu
et al., 2000), to regulate post-synaptic proteins (Grabrucker,
2014) and has an important role in the formation and main-
tenance of the structure of the post-synaptic density (PSD), a
network of proteins that links the neurotransmitter receptors
to downstream signaling components and to the cytoskeleton
(Jan et al., 2002; Grabrucker et al., 2011). Additionally, more
than 300 enzymes are zinc-dependent, many of them expressed
in the central nervous system (CNS). It is thus not surprising
that zinc deficiency, among other pathologies, leads to neu-
ronal dysfunction and in turn to characteristic neurobehavioral
changes.
There is a broad spectrum of physiological signs of zinc
deficiency given that zinc is involved in a great number
of biochemical processes. Most commonly, zinc deficiency is
associated with skin lesions, such as seen in Acrodermati-
tis enteropathica, an autosomal recessive metabolic disorder
affecting the uptake of zinc. Additionally, growth retardation
and hypogonadism in males were among the first and fre-
quently reported clinical signs in zinc deficient patients (Prasad,
2013). However, apart from several other symptoms caused by
zinc deficiency, such as poor appetite, delayed wound healing,
cell-mediated immune dysfunction, and abnormal neurosensory
changes (Prasad, 2013), behavioral alterations have been consis-
tently reported. Zinc deficiency may result in depression, emo-
tional instability, increased anxiety and aggression, irritability and
deficits in social behavior. Additionally, or as consequence of some
factors discussed above, impaired memory and capacity to learn
may occur.
Zinc deficiency is associated with multiple disorders. In par-
ticular, patients suffering from neurological disorders often show
zinc deficiencies. For example, low serum zinc levels have been
reported in Autism Spectrum Disorders (ASD), Attention deficit
hyperactivity disorder (ADHD), Mood Disorders, such as depres-
sion, Schizophrenia (SCZ), and Spinocerebellar ataxia type 2
(Pfaender and Grabrucker, 2014). Furthermore, zinc deficiency
has been observed in disorders of the gastro-intestinal (GI)
tract, such as malabsorption syndrome, Crohn’s disease, regional
ileitis and steatorrhea, as well as liver disease, renal diseases,
alcoholism, and sickle cell disease (Prasad, 2013). It is therefore
necessary to understand how zinc deficiency will influence the
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initiation and/or progression of such a disorder and modify
the disease phenotype. Here, we will focus especially on the
behavioral alterations that can be observed in zinc deficient
subjects.
Given that targeted manipulation of zinc levels in humans
is hard to achieve and ethically unacceptable, in the past, var-
ious animal models for zinc deficiency have been created and
analyzed. Zinc deficiency can be readily produced by dietary
zinc restriction using special food. In rodents fed with a zinc
deficient diet, signs of zinc deficiency occur very soon. For
example, a typical reduction in food intake is observed within
approximately 3 days (Evans et al., 2004). At the same time,
serum zinc levels are decreased (Ohinata et al., 2009). How-
ever, zinc levels in the brain are affected only after chronic
zinc deficiency. For example, 4-week zinc deprivation decreases
hippocampal zinc concentrations in rats (Takeda and Tamano,
2009). In rodents, a diet that induced marginal/mild zinc depri-
vation contains 10 µg Zn/g. A zinc content of 5–7 µg/g
is associated with moderate deprivation, and of <1–2 µg/g
with severe deprivation (Golub et al., 1995). In monkeys,
a marginal deprivation occurs at a zinc content of 4 µg/g,
moderate deprivation at 2 µg/g and severe deprivation at
<1 µg/g (with 50 µg Zn/g considered adequate) (Keen et al.,
1993).
Maternal zinc deficiency (prenatal zinc deficiency) produces
effects ranging from growth retardation and teratogenesis to
embryo/fetal death. Additionally, postnatal complications of
maternal zinc deficiency such as neurobehavioral and immuno-
logical abnormalities can occur. On the other hand, postnatal
zinc deficiency in adult life may cause specific and distinct effects
itself. Therefore, it is important to consider the different time-
points of zinc deprivation, when investigating the effects of zinc
deficiency.
Since the last 50 years, zinc, from an ignored mineral, has
now become so important that zinc deficiency is recognized as
a major worldwide public health problem. In fact, zinc defi-
ciency has been estimated to cause more than 450,000 deaths
in children under the age of 5 (Fischer Walker et al., 2009)
and about 800,000 deaths (about 1.5% of all deaths) (Nriagu,
2007) annually worldwide and is responsible for about 20%
of perinatal mortality. Mild zinc deficiency is especially com-
mon in infants, children, women, and elderly people because
of either high nutrient requirements or compromised digestion
and absorption and contributes to impaired physical and neu-
ropsychological function (Hambidge, 2000). Especially behav-
ioral alterations may pose a so far underestimated effect of
zinc deficiency and can be informative of the various path-
ways where zinc is a major functional factor in higher brain
function.
Thus, here, we will summarize the behavioral phenotypes
including effects on learning and memory abilities observed in
various animal models of zinc deficiency, among them envi-
ronmentally produced zinc deficient rodents and monkeys, as
well as transgenic mouse models with targeted disruption of a
particular zinc homeostasis gene. Moreover, we will shortly review
the limited data obtained from human studies in comparison to
the findings in zinc deficient animals.
BEHAVIORAL PHENOTYPES OF ENVIRONMENTALLY
INDUCED ZINC DEFICIENCY
Already in 1933, it was reported that zinc is essential for the
growth of rats (Todd et al., 1933). That this is also true for humans
was established in the 1960s by several reports from Prasad et al.
on patients from the Middle East (Prasad et al., 1961, 1963a,b).
However, besides overt clinical features such as growth retar-
dation, skin irritations and hypogonadism, apart from mental
lethargy, little has been reported on behavioral abnormalities in
these patients. It was only in the 1990s, when a few studies in
school-age children directly addressed the effects of low zinc diet
on behavior (Gibson et al., 1989; Cavan et al., 1993a,b). Still
today, the majority of data regarding behavioral alterations due to
zinc deficiency comes from findings in animal models. Important
studies are summarized in Table 1.
PRENATAL AND PERINATAL ZINC DEFICIENCY IN ANIMAL MODELS
Zinc deprivation is most frequently employed during the period
of most rapid fetal brain growth during pregnancy and discontin-
ued after birth. Behavioral testing is conducted later in adulthood
(usually after sexual maturation). Thus, the tested animals do not
suffer from acute zinc deficiency at the time of behavioral obser-
vation. Critical periods of susceptibility to zinc depletion during
development have been identified in rodents (Halas, 1983). For
example, severe zinc deprivation of pregnant rats during the
first or all trimesters of pregnancy, leads to teratological effects.
In contrast, mild zinc deprivation of pregnant rats during all
trimesters or severe zinc deprivation only in the last third of
gestation (embryonic day 14–20) does not induce malformations,
but could still affect brain growth and function. Several studies
on prenatal zinc deficient animals report characteristic behavioral
effects, such as altered learning and memory, attention, and
impaired social behavior. In general, the development of the
normal associational network of neurons seems to be impaired
under dietary zinc deprivation (Dreosti, 1983; Dvergsten et al.,
1984).
Deficits in learning and memory
Mice with mild or moderate zinc deficiency from day 16 of
gestation to postnatal day 15 were tested at 70 days of age in a
passive avoidance task used to evaluate learning and memory. In
this test, mice learn to avoid an environment in which an aversive
stimulus (foot-shock) was previously delivered (Golub et al.,
1983). Passive avoidance latencies were lower in both pre- and
perinatal zinc deficient groups hinting towards impaired learning
and memory. In another study, the effects of severe zinc depriva-
tion during pregnancy and lactation were assessed in adult rats (at
100 days of age) using a radial maze, a task designed to investigate
working memory, as well as short-term- and long-term memory.
The results showed a severe learning deficit and some working
memory deficit of prenatal zinc deficient animals when compared
to controls (Halas et al., 1983, 1986). Further studies were able
to repeat these findings. For example, it was reported that zinc
deficiency during pregnancy and during lactation increased the
time until rats learned to find a hidden platform when they were
tested for spatial learning and memory in a Morris water maze at
postnatal day 56 (Tahmasebi Boroujeni et al., 2009).
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Table 1 | Summary of behavioral studies on zinc deficient animals.
Phenotype Test Species Age/time-point Reference
of deprivation
Impairment in Tolman-Honzik maze at PD44 Rat PD1–PD21 Lokken et al. (1973)
learning and memory passive avoidance task (foot shock;
shuttle box) at PD60
Rat E15–E20 Halas and Sandstead (1975)
avoidance task (foot shock;
Skinner box) at PD11,14,17,20 and
PD56,59,62,65
Rat PD1–PD21 Halas et al. (1979)
passive avoidance task (foot shock;
shuttle box) at PD70
Mouse E16–PD15 Golub et al. (1983)
17-arm radial maze at PD100 Rat PD1–PD18-21 Halas et al. (1983)
visual discrimination task Monkey E111–PD116 Strobel and Sandstead (1984)
17-arm radial maze at PD100 Rat E1–PD23 Halas et al. (1986)
Morris water maze Rat adult rat, acute
hippoc. DDC and
CaEDTA infusion
Frederickson et al. (1990)
passive avoidance task (foot shock;
shuttle box) at PD84
Rat PD56–PD84 Takeda et al. (2000)
Morris water maze at PD75 Rat PD54–PD75 Keller et al. (2000)
Morris water maze Mouse PD120 acute hippoc.
DDC and CaEDTA
infusion
Lassalle et al. (2000)
fear conditioning (foot shock) Mouse PD91 acute hippoc.
DEDTC and CaEDTA
infusion
Daumas et al. (2004)
Morris water maze at PD56 Rat E1–PD21 Tahmasebi Boroujeni et al. (2009)
fear conditioning and extinction (foot
shock) at PD105
Mouse PD84–PD105 Whittle et al. (2010)
Morris water maze at PD56 Mouse PD21–PD56 Gao et al. (2011)
Morris water maze at PD56 Rat E1–PD21 Yu et al. (2013)
Impairment in social behavior interindividual aggression after
shock at PD75
Rat E14–E20 Halas et al. (1975)
including increased emotionality
(aggression/ anxiety) active avoidance (foot shock; shuttle
box) at PD75
Rat E14–E20 Sandstead et al. (1977)
Taylor’s two-choice T-maze at PD49 Rat E14–E20 Peters (1978)
Open field test; elevated plus maze
at PD35/42
Rat PD28–PD35/42 Takeda et al. (2007)
Open field test at PD56 Rat PD28–PD56 Takeda et al. (2008)
Open field test; light-dark box;
elevated plus maze at PD77
Mouse PD56–PD77 Whittle et al. (2009)
maternal resident intruder test
(aggression); maternal behavior test
(social behavior) at PD105
Mouse E1–E21 Grabrucker et al. (2014)
Enhanced stress response Tolman-Honzik maze at PD44 Rat PD1–PD21 Lokken et al. (1973)
passive avoidance task (foot shock;
shuttle box) at PD60
Rat E15–E20 Halas and Sandstead (1975)
Depression–like behavior light-dark box; Porsolt swim test at
PD84
Rat PD63–PD84 Tassabehji et al. (2008)
forced swim test at PD42 Rat PD28–PD42 Tamano et al. (2009)
novelty suppressed feeding; tail
suspension test; forced swim test;
at PD77
Mouse PD56–PD77 Whittle et al. (2009)
forced swim test at PD42 Rat PD28–PD42 Watanabe et al. (2010)
forced swim test at PD35 Mouse PD21–PD35 Młyniec et al. (2012)
tail suspension test at PD35-91 Mouse PD21–PD35-91 Młyniec and Nowak (2012)
forced swim test at PD63 Mouse PD21–PD63 Młyniec et al. (2013)
Impaired vocalization ultrasonic vocalization at PD105 Mouse E1–E21 Grabrucker et al. (2014)
The table summarizes the most commonly reported phenotypes of pre- and postnatal zinc deficient animals (E: embryonic day; PD: postnatal day). The time-point
given for behavioral testing indicates the age of the animals at the starting day of experiments.
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In another study, rats were similarly subjected to zinc defi-
ciency during pregnancy and lactation. At 56 days of age, learning
was tested using a Morris water maze. Again, prenatal zinc defi-
cient animals needed more time finding the hidden platform and
thus swam longer distances (Yu et al., 2013). Also offspring of
rhesus monkeys with a severe zinc deficiency imposed during the
third trimester of pregnancy display an impairment of learning
later in life indicated by a difficulty in retaining previously learned
visual discrimination tasks and by a difficulty in learning new
tasks (Strobel and Sandstead, 1984; Golub et al., 1985).
Taken together, prenatal zinc deficiency may lead to lasting
changes in synapse function or neuronal connectivity that mani-
fest in reduced ability of learning and memory, dependent on the
task, later in life.
Impaired social behavior (including enhanced stress response and
increased emotionality)
Altered social behavior of prenatal zinc deficient mice was
reported in multiple studies. Already in initial studies, zinc
deprived males displayed a reduced affiliation in encounters with
controls (Peters, 1978), which was attributed to increased aggres-
siveness. However, additional impairments in social behavior were
reported in the offspring of mice that experienced moderate
zinc deficiency during pregnancy. For example, prenatal zinc
deficient mice display less maternal behavior towards their pups
(Grabrucker et al., 2014).
Additionally, an enhanced stress response and emotionality
after prenatal zinc deprivation was reported that was seen to
influence the behavior of the animals in various test paradigms.
For example, early studies investigating learning in prenatal zinc
deficient rats found altered performance in shuttlebox shock
avoidance tests using a negative reinforcer (shock), and the Tol-
man Honzik maze using a positive reinforcer (food) (Lokken
et al., 1973; Halas and Sandstead, 1975). However, given that
a sudden impairment in shock-motivated learning tasks was
observed after normal initial learning, the shuttlebox test results
might be explained by an enhanced response to stress. This
enhanced stress response was also suggested to be the underlying
cause of enhanced shock-elicited aggression in female (Halas
et al., 1975) and male offspring (Sandstead et al., 1977; Peters,
1978). Moreover, in social encounters between experimental ani-
mals and control or zinc deficient rats, the zinc deficient rats
were the social partners most often avoided given their increased
aggressiveness (Peters, 1978). Similarly, prenatal zinc deficient
female mice showed increased aggression in a resident intruder
test when they were adults (Grabrucker et al., 2014).
In addition to rodent studies, studies using offspring of rhesus
monkeys with a severe zinc deficiency imposed during the third
trimester of pregnancy reported reduced activity, exploration, and
play (Sandstead et al., 1978).
POSTNATAL ZINC DEFICIENCY IN ANIMAL MODELS
When behavior is tested during a period of zinc deprivation in
immature animals, altered emotionality, lethargy, and deficits in
learning, attention, and memory are most prominent. However,
in mature animals, different or additional alterations can occur
as well as the persistence of the phenotype after restitution of
physiological zinc levels affected. For example, impaired learn-
ing behavior has been reported in zinc deficient animal models
such as rats and rhesus monkeys (Golub et al., 1995). However,
the time-point of zinc deficiency might determine, whether the
effects are reversible given that zinc deficiency during early devel-
opment elicits irrecoverable impairment, while the impairment
of learning and memory was rescued in young adult rats by
feeding a normal diet (Takeda et al., 2000). It is thus neces-
sary to carefully evaluate the time period of zinc deprivation,
the severity of deficiency, the use of pair-fed animals or ani-
mals fed ad libitum as controls, and the gender of zinc defi-
cient animals if comparisons between different studies are to
be undertaken. Additionally, other consequences of zinc defi-
ciency have to be taken into account such as the occurrence
of anorexia or growth retardation. For example, zinc deficient
monkeys who developed behavioral deficits continued to grow
during a period of accelerated post weaning growth, whereas
monkeys that showed arrested growth displayed normal behav-
ior (Golub et al., 1985). However, despite sometimes slightly
different outcomes using postnatal zinc deficient animals that
are most likely due to the non-standardized protocols used to
generate these animals, few behavioral alterations are consistently
reported.
Depression-like behavior (including lethargy)
Zinc deficiency is able to induce depressive-like behavior in adult
rodents (Młyniec et al., 2014). In multiple studies, zinc deficient
animals showed increased immobility time in the forced swim test
and tail suspension test, test paradigms to evaluate depression-
like behavior (Tassabehji et al., 2008; Tamano et al., 2009; Whittle
et al., 2009; Watanabe et al., 2010; Młyniec and Nowak, 2012;
Młyniec et al., 2012, 2013). These results obtained from rodent
studies indicate that zinc deficiency in humans might not only be
a consequence of depression but may contribute to the develop-
ment of depressive-like behavior in some cases. Furthermore, zinc
deficiency lowered the efficacy of several antidepressants (Tass-
abehji et al., 2008; Whittle et al., 2009; Młyniec and Nowak, 2012;
Młyniec et al., 2012). In line with these observations, various
studies report an antidepressant-like effect of zinc in some models
of depression (Kroczka et al., 2000, 2001; Nowak et al., 2003, 2005;
Cies´lik et al., 2007; Sowa-Kuc´ma et al., 2008; Tassabehji et al.,
2008).
Deficits in learning, attention, and memory
In early studies, rats that had been zinc deprived during the
late nursing period were investigated regarding their ability to
remember the association of two stimuli previously built through
conditioned learning. To that end, a tone coupled with a shock
was applied at 11, 14, 17 or 20 days of age. Forty-two days
later when the offspring were adults, their memory was tested
using a Skinner box. Rats that had been trained to press a bar
discontinued this behavior after the tone was presented again
in anticipation of the expected shock, indicating memory of the
association. Animals that were severely zinc deprived postna-
tally, exhibited poorer memory as adults (Halas et al., 1979).
These early findings were followed by a multitude of studies
that reported behavioral impairments regarding learning and
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memory in animals fed with a zinc restricted diet for several
weeks. In particular, impaired spatial memory and extinction
learning was consistently described (Keller et al., 2000; Whittle
et al., 2010; Gao et al., 2011). For example, after 3 weeks of
dietary zinc restriction, adult rats demonstrated significantly
longer (86.0%) retrieval escape latencies (time to relocate the
hidden platform after an initial trial) compared to controls
in a Morris water maze test (Keller et al., 2000). Similarly,
mice fed with a zinc deficient diet for 5 weeks showed impair-
ments in spatial learning in the Morris water maze (Gao et al.,
2011).
Zinc deficiency due to zinc chelating agents has also been
used to assess the role of zinc in memory. Multiple studies have
found that intra-hippocampal infusion of zinc chelators such
as diethyldithiocarbamate (DEDTC) or CaEDTA alter learning
and memory in rodents. DEDTC for example was shown to
impair performance of animals in a “delayed matching-to-place”
version of the water maze task (Frederickson et al., 1990). DEDTC
injection shortly before training suppressed the decrease in time
needed to find a platform which is normally observed on a
second run. Another study investigated the behavior of DEDTC
injected animals (intra-hippocampal) in a standard version of the
Morris water maze (Lassalle et al., 2000). The results revealed
that treatment during training prevented the mice from learn-
ing the location of a fixed hidden platform. In these experi-
mental animals, the memory impairment occurred transitory
and correlated with the time course of zinc chelation. This
indicates that no substantial damage to the hippocampus due
to the injection of chelator was responsible for the observed
behavior.
Additionally, injection of zinc chelators (both of DEDTC
and CaEDTA) was found to impair contextual fear conditioning
(Daumas et al., 2004). While acute zinc chelation blocked the con-
solidation of contextual memory, it did not show an effect on the
ability to recall information, once the memory has been formed
(Sindreu and Storm, 2011). Thus, taken together, zinc deficiency,
most likely by depleting synaptic zinc, impairs the acquisition or
consolidation of hippocampus-dependent memory. Interestingly,
under normal conditions, an age-related decrease in synaptic
zinc is observed in mouse hippocampus. This decrease correlates
with late-onset deficits in spatial reference memory (Adlard et al.,
2010).
Altered emotionality (including aggression and anxiety)
Zinc deficiency was reported to have an anxiogenic effect in mice,
which might also be related to depression-like behavior (Whittle
et al., 2009). The increased anxiety-like behavior was similarly
observed in rats. For example, in one study, after 14 days of zinc-
deprivation, the frequency of entering the center zone in the open
field test was decreased. Additionally, in the elevated plus-maze,
the time spent in the open arms was decreased (Takeda et al.,
2007). Both, the center zone of the open field and the open arms
of the maze are unprotected areas, which are less frequently visited
by anxious rodents. Additionally, after 14 days of zinc deficiency,
isolated zinc deprived mice exhibited more aggressive behavior in
the resident-intruder test, compared to isolated control mice and
showed an increased duration of aggressive behavior indicating
that aggressive behavior elicited by social isolation is enhanced by
zinc deficiency (Takeda et al., 2008).
BEHAVIORAL PHENOTYPES OF GENETIC ANIMAL MODELS WITH
TARGETED DISRUPTION OF ZINC HOMEOSTASIS GENES
To act within the brain, zinc has to be taken up from dietary
sources in the small intestine, transported via the blood circula-
tory system, actively cross the blood-brain-barrier and be taken
up into neurons or glial cells. To that end, a great variety of
zinc transporters are expressed in various tissues. There are two
families of zinc transporters in humans, ZnT (SLC30A) with at
least 10 members and Zrt- and Irt-like protein (ZIP) (SLC39A)
transporters with 15 members. ZIPs mostly mediate the uptake of
zinc and ZnTs the export (into organelles or out of cells) of zinc
and both, ZnT and ZIP transporters exhibit unique tissue-specific
expression (Roohani et al., 2013).
Within the brain, ZnT3 probably is the most investigated
zinc transporter given that it promotes the influx of zinc into
synaptic vesicles of glutamatergic neurons (Palmiter et al., 1996;
Wenzel et al., 1997; Linkous et al., 2008). Knockout of ZnT3
leads to the absence of histochemically reactive zinc in the ter-
minals of zincergic neurons (Cole et al., 1999). The role of
released zinc due to neuronal activation is not fully understood
but it is suggested that zinc has a modifying role in signal
transmission (Pan et al., 2011) and synaptic plasticity. Zinc con-
taining glutamatergic neurons are found in most parts of the
cerebral cortices and limbic structures, predominantly in the
hippocampus (Frederickson et al., 2000). These brain regions
play important roles in memory, emotions, behavior, motivation,
and in the processing of sensory information. Therefore, it is
likely that a lack of ZnT3 might lead to disturbances in these
brain functions. However, in most of the performed behavioral
experiments, ZnT3 knockout mice behaved similar to wildtype
littermates. Nevertheless, some characteristic alterations could
be observed such as age-dependent deficits in learning and
memory.
Although young ZnT3 knockout mice need more time to find
the new location of a platform in the Morris water maze tests indi-
cating slight deficits in reversal spatial learning (Cole et al., 2001;
Martel et al., 2011), in general, young ZnT3 knockout mice have
normal learning and memory functions (Cole et al., 2000, 2001;
Adlard et al., 2010). In contrast, adult ZnT3 knockout mice, show
deficits in learning and memory at 6 months of age in the Morris
water maze (Adlard et al., 2010). Further, while no impairment in
working memory was observed in a water version of the radial
arm maze, impairments in working memory were observed in
a rewarded-alternation T-maze (Cole et al., 2001; Sindreu et al.,
2011). Tests for avoiding and memorizing threatening situations,
revealed a normal passive avoidance behavior of ZnT3 knockout
mice and normal fear memory (Cole et al., 2001; Martel et al.,
2010). However, if a too complex protocol for conditioning was
used, ZnT3 knockout mice show deficits in fear memory (Martel
et al., 2010). Additionally, deficits in contextual discrimination
and contextual fear memory have been observed in association
with a higher rate of extinction (Martel et al., 2010; Sindreu et al.,
2011). Thus, taken together, ZnT3 mice, especially in old age,
display some deficits in learning and memory.
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In contrast, ZnT3 knockout mice showed no differences in
anxiety compared to their wildtype littermates (Cole et al., 2000,
2001; Adlard et al., 2010; Martel et al., 2011) and have comparable
performances in motor coordination assessed by rotarod, pole
and cagetop tests, and swim speed in water maze trials. Further,
the loss of pre-synaptic zinc does not affect auditory, olfactory
or visual abilities (Cole et al., 2000, 2001; Adlard et al., 2010;
Martel et al., 2011) and ZnT3 knockout mice show normal
nociception in tail-flick assays and hot plate tests and normal pain
sensitivity to electrical foot shocks (Cole et al., 2001; Martel et al.,
2011).
Although ZnT3 knockout mice showed increased social inter-
actions, they failed to discriminate between a familiar and an
unfamiliar mouse (Martel et al., 2011). Therefore, the increase
in social interaction might be due to deficits in social and
object recognition memory (Martel et al., 2011). In contrast
to systemically zinc deficient animals, no increase in aggressive
behavior has been observed during these tests (Martel et al.,
2011). Similarly, no decrease in motivation assessed by the swim
speed in Morris water maze and no increase in depression-
like behavior evaluated by Porsolt’s forced-swim test was seen
in ZnT3 knockout mice (Martel et al., 2010, 2011). However,
although ZnT3 knockout mice do not develop spontaneous
seizures they are prone to kainic acid induced seizures (Cole et al.,
2000).
Several mouse models with targeted deletion of other zinc
transporters have been described in detail for their phenotypic
features and zinc levels. The available genetically modified animal
models are listed in Table S1.
A homozygous deletion of ZnT1 or ZIP4 respectively is early
embryonic lethal (Andrews et al., 2004; Dufner-Beattie et al.,
2007). Both transporters show a high expression in tissues essen-
tial for zinc uptake such as intestine and the embryonic yolk sac
(Langmade et al., 2000; Dufner-Beattie et al., 2003) and thus
knockout was shown to have drastic consequences. Mutations
in the ZnT2 and the ZnT4 gene may lead to zinc deficient milk
produced by nursing mothers (lethal milk lm mice), which can
in turn cause a deficiency in the pups (Piletz and Ganschow,
1978; Erway and Grider, 1984; Huang and Gitschier, 1997;
Chowanadisai et al., 2006; Lee et al., 2013).
Knockout of ZnT5, ZnT7 or ZnT8 has tissue-specific effects
and can influence metabolic pathways. ZnT5 and ZnT7 are
thought to import zinc into the Golgi apparatus (Kambe et al.,
2002; Kirschke and Huang, 2003) and thus, knockout mice show
defects of acquisition and distribution of zinc (Inoue et al.,
2002; Huang et al., 2007, 2012). ZnT5 knockout mice show poor
growth, osteopenia, low body fat, muscle weakness and male-
specific cardiac death (Inoue et al., 2002), while knockout of ZnT7
and ZnT8 can lead to abnormal glucose and insulin metabolism
(Lemaire et al., 2009; Nicolson et al., 2009). In humans, polymor-
phisms in the ZnT8 gene are linked to an increased susceptibility
for type 2 diabetes (Sladek et al., 2007; Table S1).
In contrast to ZnT knockout animals, the consequences of
targeted deletion of ZIP transporters needs further investiga-
tion. The subfamily II of ZIPs that includes ZIP1-3 might
have important functions during the adaption to zinc defi-
ciency and possibly can serve as backup system in dietary zinc
uptake (Kambe et al., 2004). Deletion of mouse ZIP1, 2 or
3 causes no obvious phenotypic effects when dietary zinc is
present in sufficient concentrations. However, if zinc is reduced,
these knockout animal models show a higher susceptibility to
develop malformations and signs of zinc deficiency (Dufner-
Beattie et al., 2005, 2006; Peters et al., 2007). This also holds
true for a double or even a triple deletion of this subfamily of
zinc transporters (Dufner-Beattie et al., 2006; Kambe et al., 2008;
Table S1).
Moreover, mouse models are available for ZIP8, 13 and 14,
all having defects in growth or development (Fukada et al.,
2008; Hojyo et al., 2011; Gálvez-Peralta et al., 2012). Loss of
function of ZIP8 leads to defects in organ morphogenesis, and
hematopoiesis (Gálvez-Peralta et al., 2012). Knockout of ZIP13
results in abnormal connective tissue development (Fukada et al.,
2008) and knockout of ZIP14 in impaired gluconeogenesis. Addi-
tionally, deletion of ZIP14 severely affects systemic growth (Hojyo
et al., 2011). With the exception of ZnT3 and ZnT4, where lm
mutant mice show a mild ataxic phenotype, to our knowledge, no
behavioral effects of the genetic ablation of the zinc transporter or
a resulting zinc deficiency have been investigated so far.
Besides the zinc transporting proteins of the ZIP and ZnTs
family, other factors contribute to zinc homeostasis in the
brain, including Metallothioneins (MTs). MTs are small proteins
(4–14 kDa) with very high metal binding capacity. Due to a high
Cys content, metals such as zinc, cadmium and copper can be
arranged in metal-thiolate clusters. The metals are located in two
separate domains, which can in total bind up to seven metal
ions. Under physiological conditions, zinc is plentiful compared
to other putative binding metals and often the sole metallic
constituent of MTs. However, under exposure to toxic metals,
cadmium, mercury, platinum, lead, and bismuth might also be
associated with MTs. In mammals, four groups of MT have
been identified (MT-1, MT-2, MT-3, MT-4). There are wide
variations of expression in different tissues and across different
developmental states. Additionally, levels of MTs react to dietary
metal contents. Therefore, MTs can act as zinc buffering pro-
teins, temporarily storing the metal, but also participate through
targeted release of zinc in signaling pathways. While the MT-2
gene encodes a single MT-2A protein, the MT-1 gene encodes
many isoforms (MT-1A, MT-1B, MT-1E, MT-1F, MT-1G, MT-1H
and MT-1X). Both, MT-1 and MT-2 are expressed ubiquitously
including the brain (Hidalgo et al., 2001). MT-3 and possibly
MT-4 in turn are especially enriched in the CNS (Maret, 2000;
Hidalgo et al., 2001). Besides the known functions in heavy
metal detoxification, and metal buffering and transporting, MT-
3 was reported to play an additional role in neuromodulatory
events in the brain. This additional feature is also reflected in
the behavioral phenotypes of animals with targeted deletion
of MTs.
The functions of the isoforms 1–3 concerning learning, mem-
ory and behavior were investigated in several publications using
mouse models with specific deletions. MT-1 and MT-2 were
shown to play a role in the regulation of neurobehavioral activity
as well as in spatial cognitive functions with zinc acting as a
regulating factor (Levin et al., 2006; McAuliffe et al., 2008; Itoh
et al., 2010). A double knockout of MT-1/MT-2 in mice leads
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to a decreased spontaneous locomotor activity and even a higher
anxiety in the unfamiliar environment of the open field. Intrigu-
ingly, in the Morris water maze as well as in the 8-arm radial
maze, the deletion of MT-1 and 2 causes disturbance in spatial
learning (Levin et al., 2006; McAuliffe et al., 2008; Itoh et al.,
2010). This defect in memory acquisition can even be enhanced
by zinc depletion during growth in the young adult animal
(Itoh et al., 2010). Moreover, it was reported that MT-1/MT-2
null mice show a greater susceptibility to the neurobehavioral
effects caused by a prenatal mercury exposure (Yoshida et al.,
2005).
Mice lacking MT-3 show a reduction in brain zinc levels as
a result of the absence of MT-3 bound zinc. In contrast to the
MT-1/MT-2 double knockout mice, young adult MT-3 knockout
animals show no deficits in spatial learning (Erickson et al., 1997),
memory (Koumura et al., 2009) and spontaneous locomotor
activity (Erickson et al., 1997; Koumura et al., 2009). Further, no
differences in the ability to learn and remember simple associ-
ations could be observed between knockout and wildtype mice.
Equal results were obtained for 2-year-old mice. In contrast,
MT-3 knockout mice are not only much more susceptible to
kainic acid induced seizures but also show a higher mortality due
to greater severity of seizures with a longer duration of motor
convulsions and a shorter latency to seizure-onset compared to
wildtype littermates. These observations indicate a potential role
for MT-3 in the regulation of zinc during neuronal stimulation
(Erickson et al., 1997). However, ZnT3/MT-3 double knock-
out mice did not show enhanced seizure sensitivities to kainic
acid compared to ZnT3 or MT-3 knockout mice (Cole et al.,
2000).
Moreover, MT-3 knockout mice exhibit deficits in social inter-
actions in a novel environment manifesting in a significant shorter
mean duration per contact (Koumura et al., 2009). Acoustic
startle response tests indicate that MT-3 knockout mice seem to
have deficits in the ability to filter unnecessary information as
shown in a reduced prepulse inhibition (Koumura et al., 2009).
MT-3 mice have been suggested as suitable subjects to investigate
psychological disorders (Koumura et al., 2009). Taken together,
these findings suggest that MT-1 and 2, compared to MT-3 iso-
forms have quite different functions in the CNS and have distinct
influence on behavior, memory and learning.
When the concentration of intracellular free zinc reaches a
certain limit, MTF-1 (metal-responsive transcription factor-1)
is activated and induces the expression of, among other target
genes, MTs which then bind and buffer the zinc ions, and ZnT1
that exports surplus free zinc (Murakami and Hirano, 2008).
MTF-1 knockout mice unfortunately have an embryonic lethal
phenotype due to liver degeneration (Günes et al., 1998) and to
our knowledge no behavioral data of a brain specific conditional
MTF-1 knockout has been reported so far.
For a comparative overview of phenotypes associated with
knockout of zinc homeostasis genes see supplementary Table S1.
BEHAVIORAL PHENOTYPES OF HUMAN PATIENTS WITH ZINC
DEFICIENCY
In humans, similar to animal models, zinc intake seems to
be linked to a healthy mental function. Zinc deficiency may
be associated with deficits in activity, attention, altered behav-
ioral and emotional responses and impaired motor development
caused by abnormal cerebellar function (Black, 1998). Especially
at young age in times of accelerated growth, humans might display
increased susceptibility to zinc deficiency. Additionally, several
studies have found sex differences, suggesting that boys are more
prone to develop zinc deficiency than girls (Cavan et al., 1993b;
Sazawal et al., 1996).
There is a high incidence of zinc deficiency in patients suffer-
ing from ADHD, autism, SCZ, and depression. Notwithstanding
whether cause or consequence, the effects of zinc deficiency might
be observable in the behavior of the people affected by these
disorders.
In line with the increased depression-like behavior in zinc
deficient rodents (Tassabehji et al., 2008; Whittle et al., 2009),
sheep and goat show behavioral signs of zinc deficiency (Nelson
et al., 1984) such as allotriophagia, also called wool eating disease,
which includes symptoms like growth retardation, diarrhea, poor
appetite, hair loss, and atypical eating behavior of the own wool
(Ott et al., 1964; Nelson et al., 1984; Suliman et al., 1988; Alhaji
and Musa, 2012). Allotriophagia is associated with low blood
zinc levels and the symptoms can be induced experimentally
by feeding zinc deficient diets (Ott et al., 1964; Nelson et al.,
1984; Suliman et al., 1988; Alhaji and Musa, 2012). The observed
behavioral abnormalities in those animals were regarded as signs
of depression associated with hypozincemia by several authors
(Nelson et al., 1984; Suliman et al., 1988; Alhaji and Musa, 2012)
and were shown to be reversible upon zinc supplementation (Ott
et al., 1964; Nelson et al., 1984; Suliman et al., 1988; Alhaji and
Musa, 2012). The described symptoms also correlate to some
extent with the clinical signs of zinc deficiency in humans, and it
is reported that depressed patients are often zinc deficient (Maes
et al., 1994; Nowak et al., 2005; Levenson, 2006; Sowa-Kuc´ma
et al., 2008).
In particular, the severity of zinc deficiency seems to cor-
relate with the severity of depressive symptoms in patients
(Maes et al., 1994; Wójcik et al., 2006; Amani et al., 2010).
Increased anxiety is often reported as part of psychiatric dis-
orders, such as depression, panic attacks and post-traumatic
stress disorder. Patients suffering from anxiety disorder were
found to have significantly reduced plasma zinc levels com-
pared to controls (Russo, 2011; Islam et al., 2013). Anxiety
symptoms were significantly reduced after zinc supplementa-
tion (Russo, 2011). Moreover, the plasma zinc concentrations
were found inversely related to teacher ratings of anxiety in
3–5 years old boys in the Head Start program (Hubbs-Tait
et al., 2007). Additionally, anxiety- and depression-related dis-
orders are often characterized by excessive aggression (Neumann
et al., 2010). Intriguingly, a study reported that assaultive behav-
ior of young men might be associated with zinc deficiency
(Walsh et al., 1997). However, zinc deficiency is often accom-
panied with a low general nutritional status so that the occur-
rence of aggression and violent behavior might not only be
associated with low zinc levels but also with general malnutri-
tion. Aggressive behavior was shown diminished by the sup-
plementation of minerals and vitamins (Schoenthaler and Bier,
2000).
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Many infants with autism are suffering from marginal to severe
zinc deficiency. Recent findings suggest a relationship of infantile
zinc deficiency with autism (Yasuda and Tsutsui, 2013). Zinc
deficiency has been reported to occur with very high incidence
rate (up to 50%) in young autistic children (Yasuda et al., 2011)
and often occurs along with copper overload in this disorder. In
line with this, the Cu/Zn ratio was reported to correlate with
the severity of symptoms associated with autism (Faber et al.,
2009; Russo et al., 2012; Li et al., 2014). Some of the core
features of autism, such as impaired social behavior, language
and communication problems, and a restricted or stereotyped
pattern of activities have also been found in prenatal zinc defi-
cient mice (Grabrucker et al., 2014) that also display a synap-
tic dysregulation of zinc binding proteins of the Shank family.
Mutations and deletion of SHANK genes have been described
in autistic patients (Guilmatre et al., 2014). Along with the core
features, co-morbidities occur frequently in autistic patients such
as seizures and anxiety disorders that have been associated with
zinc deficiency before. Thus, although a link between autism
and prenatal zinc deficiency has not been investigated so far in
detail, it is an emerging field of interest and further research is
needed to determine the role of zinc deficiency in the pathology
of autism.
Only few studies were conducted in which the zinc sta-
tus of human participants was directly manipulated. However,
in these studies, induction of severe zinc deficiency led to a
sequence of reproducible effects. Clinical symptoms of zinc deple-
tion such as skin lesions, diarrhea, and sore throats appear
very early (King, 2011). The participants became anorexic after
2–3 days and developed neurosensory impairments in the sense
of taste and smell. Subsequently, subjects experienced lethargy
and displayed symptoms of depression, including increased irri-
tability, and poor anger management. Additionally, an impair-
ment of short-term memory was seen. At the last stage of the
experiment, the participants showed signs of cerebellar dys-
function. The participants were then supplemented with 50 mg
zinc per day, which led to a quick reversal of the symp-
toms (Henkin et al., 1975). Taken together, these data mirror
many of the behavioral changes observed in zinc deficient ani-
mals. However, most studies that manipulated the zinc status
of their participants mainly focused on other symptoms than
behavioral abnormalities like an altered immune system func-
tion. Therefore, data on behavioral changes due to zinc defi-
ciency in humans is only limited and there is need for further
investigations.
CONCLUSIONS
Due to the existence of only a very limited number of valid
biomarkers, the clinical diagnosis especially of marginal zinc
deficiency in humans remains problematic (Roohani et al., 2013).
Determination of zinc levels in blood plasma or serum is currently
the most commonly used method to evaluate the zinc status of
an individual although there are major limitations in validity
and reliability for the identification of mild zinc deficiency in
individuals given that serum zinc concentrations may fluctuate by
as much as 20% during a day (Hambidge et al., 1989). Assessment
of zinc levels in hair samples via inductively coupled plasma
mass spectrometry (ICP-MS) might be a preferable method.
However, still, zinc deficiency, especially mild or transient defi-
ciencies are hard to detect in humans and zinc deficiency is
commonly overlooked. Thus, the exact prevalence of mild zinc
deficiency is currently not known due to the inconsistency of
clinical symptoms (Willoughby and Bowen, 2014). Particularly,
mild zinc deficiency might not cause typical skin lesions or
anorexia. Impaired night vision, depressed wound healing or
altered immune function may not be perceived or associated
with zinc status by an individual. Also, signs associated with zinc
deficiency in babies that have been documented in several case
reports, such as excessive crying, irritability, and inconsolability
(Sivasubramanian and Henkin, 1978; Aggett et al., 1980) cannot
be used as indicators given the many possible underlying causes
for these symptoms. Thus, whereas for type 1 nutrients, where a
low tissue concentration causes an impairment of one or more
specific functions, deficiency of zinc as a type 2 nutrient gives
rise to rather nonspecific symptoms, such as reduced growth,
skin lesions, or infection. The tissue concentration of a type
2 nutrient is fixed and varies little even in times of depletion.
In contrast, a small vulnerable pool that must be sustained by
continuous dietary supply is depleted quickly (Golden, 1989).
However, because zinc is a type 2 nutrient, the response to zinc
repletion occurs also very fast (Golden, 1989). Compared to
the symptoms mentioned above, changes in behavior, such as
increased anxiety, irritability and depression might even be better
markers for zinc deficiency.
BEHAVIORAL IMPAIRMENTS ASSOCIATED WITH ZINC
DEFICIENCY—LESSONS FROM ANIMAL STUDIES
Zinc deficiency in animals produces several characteristic and
reproducible behavioral effects depending on the severity and
developmental time-point of zinc deprivation (Figure 1). Altered
emotionality including depression-like behavior, altered states of
anxiety, and aggression, as well as altered social behavior and
impaired memory and learning seem to be the most common
outcomes of zinc deficiency in animal models. Behavioral effects
of zinc deficiency are specific in animals with pre- and perinatal
zinc deprivation, postnatal zinc depletion, and altered zinc home-
ostasis due to genetic manipulation, although some overlap exists.
Some of the behavioral alterations in animal models can be found
mirrored in the behavior of human zinc deficient individuals.
However, the behavioral alterations observed in animal studies
are produced by zinc deficiency in isolation from any other
nutritional deprivation. The experimental animals are housed
under optimal environmental conditions and do not suffer from
secondary health problems. This is in contrast to the human
situation, where zinc deficiency is mostly caused by malnutrition.
Here, often multiple deficiencies of nutritional factors might
exist in parallel and the physical condition in general might be
affected. Thus, while in an animal study, a direct causal rela-
tionship between a behavioral alteration and zinc deficiency can
be established, in human studies other factors might contribute
to and modify the behavioral outcomes (Golub et al., 1995).
Therefore, in human studies, it is necessary to not only correlate
behavioral changes to the occurrence of zinc deficiency, but also to
evaluate, how zinc supplementation might influence the observed
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FIGURE 1 | Comparative overview of behavioral alterations reported
associated with zinc deficiency in animals and humans. Animal models
for zinc deficiency (left) are distinguished into animals with pre- and perinatal
zinc deprivation (blue color), postnatal zinc depletion (red color), and altered
zinc homeostasis due to genetic manipulation (green color). Specific
impairments are shown within a circle in case they only occurred in this
particular animal model and within circles if they occurred in more than one
group. Some of the behavioral alterations in animal models can be found
mirrored in the behavior of human (right) zinc deficient individuals. Only
impairments with strong validation are shown. Although possibly more
similarities between zinc deficient humans and animals exist, more research
on human zinc deficiency is necessary to exclude confounding factors.
phenotype. Here, clearly more controlled studies are needed in
the future.
Animal studies reflect effects based on the timing and mag-
nitude of zinc deficiency and thus provide information on the
brain’s need for zinc at the time of the deficit. Severe fetal and
neonatal zinc deficiency reveals an important role for zinc in
cell division, neurogenesis, stem cell proliferation and growth
hormone function, based on the observed teratogenesis and
growth retardation. Mild fetal and neonatal zinc deficiency in
turn seems to affect the behavior of the offspring, measurable
even in adult life. Thus, zinc has an additional important role
in synaptic plasticity establishing regional connectivity. Postnatal
zinc deficiency also influences the behavior of animals. However,
while social, and memory and learning impairments prevail in
prenatal zinc deficient animals, acute postnatal zinc deficiency
seems to lead to depression-like behavior, which might reflect
a role for zinc in acute synapse function. Unfortunately, so
far, no detailed behavioral studies of animal models for cer-
tain disorders such as autism, Alzheimer’s disease, Amyotrophic
lateral sclerosis, or diabetes that have been subjected to zinc
deficiency to observe a possible modulatory effect have been
performed. Finally, genetic models underline the findings of
studies with animals on a zinc deficient diet. Although very
few data is available on the behavior of mice with targeted
deletion of zinc transporters, mice with knockout of those zinc
homeostasis genes that might play a major role in the brain,
such as ZnT3 and MT-3 indeed show behavioral impairments.
Unfortunately, mice with deletion of ZnT1, a post-synaptic zinc
transporter, are embryonic lethal. However, it would not be
surprising to find subtle behavioral phenotypes also in other
ZnT and ZIP knockout mice, given that most of them are also
expressed in the brain, or based on a developmental impairment
that also affects CNS development. For example, ZIP2 might be
involved in neuronal zinc uptake and careful behavioral analysis
might reveal subtle but interesting phenotypes. Finally, especially
genetic deletion of brain zinc signaling genes such as ZnT3,
MT-3, ZIP1, ZIP3, and the post-synaptic zinc receptor GPR39,
reveals a role of zinc in influencing the susceptibility to develop
seizures.
CROSSTALK BETWEEN ZINC DEFICIENCY AND OTHER
DISORDERS—LESSONS FOR HUMAN STUDIES
The fact that mild zinc deficiency leads to rather unspecific
symptoms in humans but occurs frequently as co-morbidity in
several disorders makes the contribution of zinc deficiency to the
pathology of a particular disorder hard to recognize. Therefore,
even if diagnozed, zinc deficiency might not get the necessary
attention in the treatment of a disorder although one could spec-
ulate about various ways how impaired zinc homeostasis might
contribute mechanistically to the disease phenotype (Figure 2).
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FIGURE 2 | Comparative overview of alterations reported in specific
human diseases that share a behavioral pathology possibly associated
with zinc deficiency. Zinc deficiency is commonly reported in ASD, ADHD,
Alzheimer’s Disease (AD), Schizophrenia (SCZ), and Mood Disorders (MD).
Symptoms and comorbidities labeled in red are known to be associated with
zinc deficiency. The inner pentagon summarizes symptoms and
co-morbidities that co-occur in ASD, ADHD, AD, SCZ and MD (symptoms and
co-morbidities that are written in italic do not appear in all five disorders:
language and communication problems have not been reported to occur in
MD. ADHD or MD patients do not suffer from seizures more frequently
compared to healthy controls). “Impaired language and communication”
includes impaired language functions, absence, delayed or reduced speech,
speech problems and talking in a dull or monotonous way. Unstable
relationships, difficult peer relations, the loss of empathy, social withdrawal
and the reduced interest in social interactions are summarized by “impaired
social interactions”. “Increased anxiety” implies panic disorder, posttraumatic
stress disorder (PTSD), obsessive or compulsive disorder, and anxiety
disorder. “Sleep disturbances” include trouble sleeping, daytime sleepiness
such as longer “sleep onset latency,” frequent night-time awakenings and
reduced sleep duration. Irritability, agitation, apathy, aggression, anhedonia,
and self-injurious behavior are summarized by “behavioral abnormalities”.
“Depression-like” behavior combines depressive mood, impaired motivation
and initiative, loss of drive, decreased interest in previous activities, and
feelings of hopelessness and helplessness. “Cognitive impairments”
summarize thought disorder, lack of ability to begin or sustain planned
activities, impaired executive functions (ability to understand information and
use them to make decisions), problems with working memory, learning
disability, impaired reasoning and handling of complex tasks, learning and
memory deficits. “Attention deficits” implies inattention, trouble
concentrating or making decisions and diminished concentration. The outer
pentagons contain the core features of each disorder that are important for
diagnosing the disorder. It is visible that the mentioned disorders share
similarities, in particular in co-morbidities that frequently occur in these
disorders, that are associated with zinc deficiency. Further research is needed
to investigate, whether these co-morbidities are caused or modified by zinc
deficiency.
In particular, the influence on synaptic function, inflammation
and oxidative stress may be a common theme relevant to several
disorders.
For example, zinc is a second messenger for immune cells and
zinc deficiency affects T helper subset 1 cells and the activity
and function of macrophages and their precursors, monocytes
(Shankar and Prasad, 1998; Haase and Rink, 2007; Rosenkranz
et al., 2011). An impaired immune system certainly is a modifying
factor for any disorder, specifically also in neurodegenerative and
neuropsychiatric disorders such as depression, but immune sys-
tem alterations during pregnancy have also been reported as risk
factor for autism (Grabrucker, 2012). Intriguingly, zinc deficiency
also leads to a decrease in insulin-like growth factor 1 (IGF-1)
levels independent from a reduction of total energy intake in
rodents and humans (Cossack, 1991; Ninh et al., 1995; Ohlsson
et al., 1998). Besides the consequences on the regulation of cell
cycle and cell division that might underlie the observed growth
retardation, IGF-1 was shown to be a potent factor in synaptic
development and function, including effects on neurogenesis and
synaptogenesis (O’Kusky et al., 2000). Indeed, IGF-1 levels were
found significantly decreased in patients with autism compared
to healthy controls (Riikonen et al., 2006) and IGF-1 treatment
has shown beneficial effects in animal studies and was intro-
duced as an experimental treatment for ASD (Canitano, 2014).
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Additionally, prenatal zinc deficiency in animal models influences
Shank3, a well described autism-associated gene, at synapses
(Grabrucker et al., 2014). It is thus possible that zinc deficiency,
in particular prenatal and early postnatal zinc deficiency has a
so far underestimated role in the etiology of autism. In line with
this, zinc intake was positively related to social behavior in girls
in a cohort of Egyptian children aged 7–10 years (Wachs et al.,
1995).
Via the NF-κB pathway, zinc is able to down-regulate the
production of inflammatory cytokines and thus might act as
anti-inflammatory agent (Prasad et al., 2011). Oxidative stress
and increased inflammatory cytokines have been shown to con-
tribute to several diseases, especially those associated with aging.
Especially elderly subjects are at risk to develop zinc deficiency,
also in the Western world (Prasad et al., 1993, 2007; Briefel
et al., 2000). A study conducted in five European countries
reports an incidence rate of zinc deficiency in 31% of people
over 60 years of age (Marcellini et al., 2006) with some variation
between different countries. However, particularly hospitalized
elderly individuals might be at risk to develop zinc deficiency,
indicated by a study that reports a prevalence of 28% among
this group (Pepersack et al., 2001). Thus, disorders occurring
mostly in an aged population such as Alzheimer’s disease and
other neurodegenerative disorders but also diabetes mellitus type
2 and atherosclerosis may be particularly influenced by zinc
deficiency.
Alzheimer’s disease patients as well as patients suffering
from dementia in general show an increased incidence rate of
depression. Approximately 20–30% of patients with Alzheimer’s
disease have depression. This rate seems to remain constant
across dementia stages (Enache et al., 2011). Apart from depres-
sion, patients with dementia often present additional psychi-
atric symptoms and behavioral disturbances. Unfortunately, to
our knowledge, no studies comparing the rate of zinc defi-
ciency in this subgroup of demented patients with demented
patients without co-morbidities have been performed so far.
However, one study compared the prevalence of zinc deficiency
in several psychogeriatric patient groups to the prevalence in
a healthy control group and found an incidence rate of 41.0%
in the patient group and 14.4% in the control group (Grønli
et al., 2013). There were no significant differences between
patients with depression as their main diagnosis and patients
with depression as a co-morbid diagnosis, which might imply
that in both groups, zinc deficiency might contribute to the
occurrence of depression. Additionally, among the patients with
dementia, a similarly high rate of zinc deficiency (48.5%) was
found. The individuals with dementia in this patient group
showed severe behavioral disturbances or psychiatric symp-
toms, such as psychosis, depression, or anxiety (Grønli et al.,
2013).
The existence of diabetes mellitus is associated with anxiety
disorders and doubles the probability of depression occurrence
(Gavard et al., 1993; Ali et al., 2006; Knol et al., 2006; Golden et al.,
2008), which was associated with hyperglycemia. However, zinc
deficiency is also rather common in this patient group (Kinlaw
et al., 1983). Finally, an association of depression and atheroscle-
rosis has been reported in multiple studies (Saleptsis et al., 2011).
It is thus possible that zinc deficiency is a modifier in several
disorders mostly affecting the elderly and its outcome might be
best visible by increasing anxiety and depression-like symptoms.
On a molecular level, zinc deficiency might induce depression
by a number of possible mechanism such as modification of
neurotransmitter systems, particularly serotonergic and gluta-
matergic, neurotrophic factors, antioxidant mechanisms, and reg-
ulation of neuronal precursor cells (Cope and Levenson, 2010).
For example, zinc levels influence the density of 5-HT1A and
5-HT2A serotonin receptors, modulate glutamate signaling via
N-methyl-D-aspartate (NMDA) receptors, and alter the level of
reactive oxygen species (ROS) and brain-derived neurotrophic
factor (BDNF) and its tyrosine kinase receptor B (TrkB; Cope and
Levenson, 2010).
However, the role of zinc in the human body is so manifold
that the attempt to attribute a certain zinc dependent mecha-
nism or pathway to the etiology or pathology of a disorder is
doomed by the innumerable crosstalk between zinc dependent
mechanisms that all might be affected in parallel but to a dif-
ferent extent. Moreover, to draw conclusions from affected zinc
dependent functions on a certain observed behavioral outcome is
difficult, especially given the magnitude of other cultural, social
and physiological factors influencing human behavior. Never-
theless, based on the current knowledge from animal studies,
it is safe to conclude that zinc deficiency influences animal
behavior and will act on human behavior dependent on the
developmental time-point of zinc deprivation and might modify
the pathology of various diseases (Figure 2). It is visible that
several pathologies such as ASD, ADHD, Alzheimer’s Disease,
SCZ, and Mood Disorders share similarities, in particular in
comorbidities that frequently occur in these disorders, that are
associated with zinc deficiency. To investigate, whether these co-
morbidities are caused or modified by zinc deficiency, detailed
clinical studies have to be performed. In addition, in future,
bioinformatics approaches will hopefully help to simulate the
various possible outcomes of zinc deficiency on a molecular level
and help to unravel the impact of altered zinc signaling in specific
disorders.
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